相关实验视频

Updated: Jun 15, 2025

Electrospun Nanofiber Scaffolds with Gradations in Fiber Organization

Electrospun Nanofiber Scaffolds with Gradations in Fiber Organization

Published on: April 19, 2015

一个电DFO加载的微球/SAIB系统通过HIF-1α激活对血管化骨再生进行血管生成-骨质生成合

Xujia Shan¹, Xiaoyan Yuan¹, Xiaohong Wu¹

¹Chongqing Key Laboratory of Oral Diseases, Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Chongqing Municipal Health Commission Key Laboratory of Oral Biomedical Engineering, College of Stomatology, Chongqing Medical University, Chongqing 401147, China.

|June 13, 2025

概括

这项研究开发了一种可注射的除胺 (DFO) 装载的微球仓库,用于骨修复. 该系统通过通过HIF-1α激活协调血管新生和骨质新生来增强血管化骨再生.

科学领域:

生物材料科学生物材料科学
再生医学是一种再生医学.
组织工程是组织工程.

背景情况:

血管化对于骨缺陷修复至关重要,但目前的治疗方法有局限性.
自主移植和生长因子缺乏时空控制,并可能产生副作用.
作为缺氧模仿剂的德费洛克萨 (DFO) 可以促进血管生成.

研究的目的:

设计一个可注射的DFO装载的微球仓库 (DFO-MS@SAIB) 以提高血管化骨再生.
为了实现持续的DFO释放同步血管新生和骨质新生.
通过HIF-1α通路激活来研究作用机制.

主要方法:

电子喷雾被用来制造DFO装载的多 (乳酸-co-甘油酸) 微球 (DFO-MS).
DFO-MS与酸盐异酸盐 (SAIB) 结合,形成一个可注射的储存库.
在体外研究中评估了血管新生和骨质新生,而在体内研究中使用了老鼠形缺陷模型.

主要成果:

DFO-MS@SAIB系统证明了持续的DFO释放,促进了内皮细胞的增殖和迁移.
内皮细胞促进了骨髓 stromal 细胞迁移和骨质分化.
在体内,该系统显著增强了血管化骨再生,增加了骨体积和新的骨面积.

结论:

通过持续的DFO释放和HIF-1α信号,DFO-MS@SAIB系统有效地促进骨再生.
血管新生与骨质新生结合的效应促进了血管化骨的修复.
这种可注射仓库为治疗关键大小的骨缺陷提供了一个有希望的策略.

关键词:

在HIF-1α信号通路中.血管新生是因为血管新生.德费洛克萨胺 (deferoxamine) 是一种可以骨质发生过程 (osteogenesis)聚 (乳酸-co-甘油酸) 微球的微球.

更多相关视频

Electrospinning Growth Factor Releasing Microspheres into Fibrous Scaffolds

Electrospinning Growth Factor Releasing Microspheres into Fibrous Scaffolds

Published on: August 16, 2014

Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair

Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair

Published on: September 7, 2017

相关概念视频

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...